LEXINGTON, Ky. (KT) – Attorney General Russell Coleman announced Thursday that 51 organizations across Kentucky were awarded a total of $12,029,053 in grant funding from the Kentucky Opioid Abatement Advisory Commission to bolster prevention, treatment and enforcement efforts. Earlier this month, the Commission voted to approve the grant awards after considering more than 160 applications seeking over $85 million. The …

A data-driven intervention that engaged communities to rapidly deploy evidence-based practices to reduce opioid-related overdose deaths – such as increasing naloxone distribution and enhancing access to medication for opioid use disorder – did not result in a statistically significant reduction in opioid-related overdose death rates during the evaluation period, according to results from the National Institutes of Health’s HEALing (Helping to End Addiction …

Metonitazene is an analgesic compound related to etonitazene, which was first reported in 1957. It has been shown to have approximately 1000 times the potency of morphine by central routes of administration, but if used orally it has been shown to have the approximately 10 times the potency of morphine. Its effects are similar to other opioids such as fentanyl …

WASHINGTON, D.C. – Today, 78 leading public health, medical, education, community and other organizations urged the U.S. Food and Drug Administration (FDA), the U.S. Department of Justice (DOJ) and the U.S. Customs and Border Protection (CBP) to utilize all the enforcement tools at their disposal to clear the market of unauthorized e-cigarette products, including flavored products that appeal to kids and put …

“Allen” was a normal teen — excelling in sports, headed for university after graduation, no signs of mental disorder — when his personality did a 180-degree turn over two weeks. Uncharacteristic over-confidence and lack of sleep spiralled into rapid speech, a God complex. He was “the smartest being in the universe.” “He had it in his brain that he was …

The Biden administration’s recent move to reschedule marijuana from Schedule I to Schedule III has been drawing criticism from activists on both sides of the issue. For those focused on science and medical efficacy, it’s a move that fails to recognize the growing body of scientific and medical data that shows today’s marijuana is more addictive and more harmful than …

Depression is common among older adults, but it isn’t a normal part of aging. It can affect how you feel, think, and act. While dealing with depression can be difficult, you don’t need to tackle it alone. That’s why it’s important to seek support from family, friends, and health care professionals early on. If you’re struggling, it’s okay to share …

In this cross-sectional study from 2011 to 2021, an estimated 321 566 community-dwelling children in the US lost a parent aged 18 to 64 years to drug overdose, and the rate of children who lost a parent to overdose increased during this period. In 2021, the highest rate was found among non-Hispanic American Indian and Alaska Native individuals. The findings indicate …

Today, DEA Administrator Anne Milgram announced the release of the 2024 National Drug Threat Assessment (NDTA), DEA’s comprehensive strategic assessment of illicit drug threats and trafficking trends endangering the United States. For more than a decade, DEA’s NDTA has been a trusted resource for law enforcement agencies, policy makers, and prevention and treatment specialists and has been integral in informing …

Starting people with opioid use disorder on extended-release, injectable naltrexone (XR-naltrexone) within five to seven days of seeking treatment is more effective than the standard treatment method of starting within 10-15 days, but requires closer medical supervision, according to results from a clinical trial supported by the National Institutes of Health’s (NIH) National Institute on Drug Abuse (NIDA). Published in JAMA Network Open, …